T. Rowe Price Investment Management’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
Other funds holding INSM
BBA
DGM
OAG
T. Rowe Price Investment Management's INSM Position: Q2 2026 in Review
T. Rowe Price Investment Management opened a new position in Insmed (INSM) in Q2 2026: 1,622,675 shares worth $173M. The stake represents 0.11% of the portfolio and ranks #201 among its holdings. This is a return to the name: T. Rowe Price Investment Management previously reported a position in INSM as recently as Q4 2025.
T. Rowe Price Investment Management first reported a position in INSM in Q3 2022 and has held it in 14 quarters since. The position peaked at $210M in Q3 2023. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.
- T. Rowe Price Investment Management held 1,622,675 shares of Insmed worth $173M as of Q2 2026.
- Insmed was a new T. Rowe Price Investment Management position in Q2 2026.
- Insmed made up 0.11% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #201 holding.
- T. Rowe Price Investment Management first reported a position in Insmed in Q3 2022 and has held it in 14 quarters since.
- T. Rowe Price Investment Management's Insmed position peaked at $210M in Q3 2023.
- 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.
Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.